Salil Patel

SVP, Head of Medical Affairs at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Salil Patel's Colleagues at Alnylam Pharmaceuticals
Colleen Fossett

Business Account Executive- Rare Disease

Contact Colleen Fossett

Daniel Sum

Sr. Director, Pharmacovigilance Operations

Contact Daniel Sum

Anthony Sclafani

Director, Commercial and Medical IT

Contact Anthony Sclafani

Genie Dubuk

Vice President, Business Unit Lead Rare Disease

Contact Genie Dubuk

John Magee

VP, US Business Lead, Givosiran & Lumasiran

Contact John Magee

View All Salil Patel's Colleagues
Salil Patel's Contact Details
HQ
(617) 551-8200
Location
Skillman, New Jersey, United States
Company
Alnylam Pharmaceuticals
Salil Patel's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Salil Patel
Salil Patel currently works for Alnylam Pharmaceuticals.
Salil Patel's role at Alnylam Pharmaceuticals is SVP, Head of Medical Affairs.
Salil Patel's email address is ***@alnylam.com. To view Salil Patel's full email address, please signup to ConnectPlex.
Salil Patel works in the SaaS industry.
Salil Patel's colleagues at Alnylam Pharmaceuticals are Colleen Fossett, Kenji Fujita, Daniel Sum, Saeho Chong, Anthony Sclafani, Genie Dubuk, John Magee and others.
Salil Patel's phone number is (617) 551-8200
See more information about Salil Patel